Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-08-017934
Filing Date
2008-03-27
Accepted
2008-03-27 17:07:13
Documents
14
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 v106614_20f.htm 20-F 2742980
2 GRAPHIC page2.jpg GRAPHIC 6999
3 v106614_ex10-28.htm EX-10.28 518676
4 v106614_ex10-29.htm EX-10.29 312600
5 v106614_ex10-34.htm EX-10.34 484923
6 v106614_ex10-35.htm EX-10.35 341642
7 v106614_ex10-36.htm EX-10.36 558967
8 v106614_ex21-1.htm EX-21.1 4074
9 v106614_ex23-1.htm EX-23.1 4144
10 v106614_ex23-2.htm EX-23.2 5346
11 v106614_ex31-1.htm EX-31.1 11761
12 v106614_ex31-2.htm EX-31.2 11878
13 v106614_ex32-1.htm EX-32.1 10608
14 v106614_ex99-1.htm EX-99.1 12753
  Complete submission text file 0001144204-08-017934.txt   5031526
Mailing Address 711 EXECUTIVE BOULEVARD SUITE Q VALLEY COTTAGE NY 10989
Business Address 711 EXECUTIVE BOULEVARD SUITE Q VALLEY COTTAGE NY 10989 972-8-930-4440
XTL BIOPHARMACEUTICALS LTD (Filer) CIK: 0001023549 (see all company filings)

EIN.: 000000000
Type: 20-F | Act: 34 | File No.: 000-51310 | Film No.: 08715775
SIC: 2834 Pharmaceutical Preparations